BR0210835A - Moléculas de agrecanase - Google Patents

Moléculas de agrecanase

Info

Publication number
BR0210835A
BR0210835A BR0210835-6A BR0210835A BR0210835A BR 0210835 A BR0210835 A BR 0210835A BR 0210835 A BR0210835 A BR 0210835A BR 0210835 A BR0210835 A BR 0210835A
Authority
BR
Brazil
Prior art keywords
agrecanase
molecules
enzyme
agrecana
proteins
Prior art date
Application number
BR0210835-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Michael J Agostino
Elizabeth Di Blasio
Edward R Lavallie
Lisa A Racie
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0210835A publication Critical patent/BR0210835A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BR0210835-6A 2001-07-05 2002-07-05 Moléculas de agrecanase BR0210835A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30305101P 2001-07-05 2001-07-05
US34913302P 2002-01-16 2002-01-16
PCT/US2002/021056 WO2003004607A2 (en) 2001-07-05 2002-07-05 Aggrecanase molecules

Publications (1)

Publication Number Publication Date
BR0210835A true BR0210835A (pt) 2004-07-13

Family

ID=26973233

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210835-6A BR0210835A (pt) 2001-07-05 2002-07-05 Moléculas de agrecanase

Country Status (9)

Country Link
US (1) US20030148306A1 (https=)
EP (1) EP1409658A4 (https=)
JP (1) JP2004533841A (https=)
BR (1) BR0210835A (https=)
CA (1) CA2451374A1 (https=)
MX (1) MXPA03011715A (https=)
NZ (1) NZ530949A (https=)
PL (1) PL367675A1 (https=)
WO (1) WO2003004607A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2475329A1 (en) * 2002-02-05 2003-08-14 Katy E. Georgiadis Truncated aggrecanase molecules
AU2003261269A1 (en) * 2002-07-29 2004-02-16 Wyeth Modified adamts4 molecules and method of use thereof
BRPI0414423A (pt) * 2003-09-16 2006-11-14 Pharmacia Corp inibidores de pace4, suas composições farmacêuticas e respectivos usos
EP1737973A1 (en) * 2004-04-16 2007-01-03 Wyeth Truncated adamts molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419446A (en) * 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
JP2001008687A (ja) * 1999-06-25 2001-01-16 Yamanouchi Pharmaceut Co Ltd 新規金属プロテアーゼ及び該金属プロテアーゼ遺伝子
EP1234042A1 (en) * 1999-10-25 2002-08-28 Millennium Pharmaceuticals, Inc. Protein 27875, a human adam-ts homolog
EP1134286A3 (en) * 2000-03-14 2003-05-02 Pfizer Products Inc. Adamts polypeptides, nucleic acids encoding them, and uses thereof

Also Published As

Publication number Publication date
PL367675A1 (en) 2005-03-07
WO2003004607A3 (en) 2003-07-31
US20030148306A1 (en) 2003-08-07
JP2004533841A (ja) 2004-11-11
CA2451374A1 (en) 2003-01-16
MXPA03011715A (es) 2004-03-19
EP1409658A4 (en) 2006-08-23
WO2003004607A2 (en) 2003-01-16
EP1409658A2 (en) 2004-04-21
NZ530949A (en) 2005-09-30

Similar Documents

Publication Publication Date Title
DK1124846T3 (da) Nukleotid- og proteinsekvenser af Nogo-gener og derpå baserede fremgangsmåder
NO961812D0 (no) Humanproteaseinhibitorer av Kunitz-type
ATE530643T1 (de) Säureaktive fungale protease
ECSP088262A (es) Proteínas de fusión de albúmina
EA200970263A1 (ru) Полностью человеческая высокопродуктивная система получения усовершенствованных антител и белков
HUP0300369A2 (hu) Többértékű antitestek és alkalmazásuk
BRPI0608076A2 (pt) método de seleção, processo para purificação de oligÈmeros beta-a não difusìveis, anticorpos seletivos contra os ditos oligÈmeros beta-a não difusìveis e um processo para fabricação dos ditos anticorpos
ATE415423T1 (de) Immunisierungstherapie zur behandlung von atherosklerose
ATE484587T1 (de) Ldcam genannte moleküle
NO20052928L (no) Nye kjemiske forbindelser
BR0208265A (pt) Redução estereosseletiva de acetofenona substituìda
BR0210905A (pt) Anticorpos especìficos para cd44v6
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
SG158739A1 (en) Aggrecanase molecules
BR0313795A (pt) Processo para a hidrogenação enantiosseletiva de aminoálcoois
BR0210835A (pt) Moléculas de agrecanase
NO930428L (no) Proteinstrukturen til plantetoksingelonin
ATE395602T1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
DE10294286D2 (de) Herstellung von trägergebundenen Molekülen
WO2002033093A3 (en) Aggrecanase molecules
BR0114719A (pt) Moléculas de aggrecanase
WO2003064597A3 (en) Aggrecanase molecules
ATE382637T1 (de) Rezeptor-tyrosine-kinase gene
BRPI0410384A (pt) compostos, processo para a preparação desses compostos, composições farmacêuticas que comprendem os mesmos, método para o tratamento e/ou profilaxia de enfermidades que são moduladas por inibidores de ptp1b e sua utilização
BR0214103A (pt) N-metil-homocisteìnas e sua aplicação bem como processos para a sua preparação

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.